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Glycoproteins: glycan presentation and protein-fold stability
Mark R Wormald* and Raymond A Dwek
Glycosylation of proteins has been shown to play a role in a
variety of cellular events. Thanks to recent advances in
obtaining conformational constraints across glycosidic
linkages, structural characterisation of glycoproteins has
improved considerably. It is now becoming apparent that
N-glycosylation of a folded protein can have a significant
stabilising effect on large regions of the backbone structure.
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Introduction
The term ‘glycobiology’, introduced in 1988, focused
attention on the role of oligosaccharides in the context of
the proteins to which they were attached. Inspection of
the protein databases suggests that as many as 70% of pro-
teins have potential N-glycosylation sites (Asn-X-Ser,
where X is not proline). Glycans can affect the physical
properties of the proteins to which they are attached and
provide lectin-recognition sites. Thus, roles for glycosyla-
tion have been shown in protein folding in the endoplas-
mic reticulum, transport and secretion, anchoring of
proteins and protease protection. It is now becoming
apparent that glycans can also have a direct structural role,
affecting the tertiary or quaternary fold of the protein.
This review focuses on the structural properties and roles
of N-linked glycans.
Glycan structures
Oligosaccharide structures are determined by characteris-
ing the glycosidic linkages between the rigid monosaccha-
ride units. In practice this has been difficult to do. Very
few oligosaccharides or glycoproteins crystallise or give
resolved electron density for the entire glycan, because of
glycan heterogeneity and flexibility. Nuclear magnetic
resonance (NMR) spectroscopy has frequently given too
few constraints across glycosidic linkages for full character-
isation, whilst linkage flexibility leads to average con-
straints being determined. Molecular modelling studies
depend on the development of suitable forcefields.
However, the combination of these three techniques,
together with improvements in methodology, is now
allowing a more accurate picture of the conformational
behaviour of individual linkages to be obtained. Recently,
we compiled a database of all the crystallographic informa-
tion on the glycans attached to proteins and bound to
lectins, providing average structures for glycosidic link-
ages [1]. Advances in NMR techniques, particularly the
measurement of heteronuclear coupling constants [2] and
the ability to measure weaker nuclear Overhauser effects
(NOEs), now provide considerably more conformational
constraints. Optimised forcefields for oligosaccharides
(recently reviewed in [3]) have improved the quality of
the calculated results so that unrestrained calculations can
be performed with some confidence. Figure 1 shows a
typical set of results obtained for a terminal
Manα1–2Manα (where Man is mannose) linkage in the
oligomannose oligosaccharide, Man9GlcNAc2 (where
GlcNAc is N-acetylglucosamine). NMR data (Figure 1a)
can be used to show that there is not a unique conforma-
tion and provide considerable constraints on the range of
conformations that are allowed. The molecular dynamics
results (Figure 1b) indicate that the linkage adopts two
flexible conformations in equilibrium, the combination of
which is consistent with the NMR data. The X-ray data
(Figure 1c) show that both linkage conformations pre-
dicted by molecular dynamics are actually observed in
crystal structures.
The number of stable conformers and degree of flexibility
varies with the linkage and monosaccharide sequence.
For instance, the Glcα1–2Glcα1–3Glcα (where Glc is
glucose) trisaccharide forms a rigid unit [4], probably due
to hydrogen bonding between the first and third residues.
Another example is the branched Lexis X epitope
(Galβ1–4(Fucα1–3)GlcNAc; where Gal is galactose and
Fuc is fucose) where hydrophobic stacking between the
Fuc and Gal rings leads to a relatively rigid system [5].
Longer-range steric interactions may also reduce linkage
flexibility, as is observed in multiantennary glycans [6].
One of the questions that still has to be answered is
whether the whole structure of an oligosaccharide can be
characterised by the conformation and flexibilities of the
isolated individual linkages present in the structure.
Interestingly, molecular dynamics simulations of
Man9GlcNAc2 [7] suggest that, because of correlated
motions of the linkages, the overall topology of the mol-
ecule (Figure 2a) is better defined than expected from
the high degree of individual linkage flexibility. This
may be a result of solvent-mediated hydrogen bonds
between the antennae of the structure providing signifi-
cant conformational constraints (Figure 2b). Perhaps
more speculatively, this may arise from dampening of
large-scale motions by the solvent shell.
Conformation of the linkage between protein and N-glycan
The conformational behaviour of the linkage between an
N-glycan and its asparagine sidechain has been well charac-
terised by NMR studies of glycopeptides in solution [8,9]
and by a statistical survey of crystallographic data [10].
These show the asparagine linkage to be relatively rigid and
planar, with a tendency to extend the first glycan residue
away from the peptide backbone and into the solvent.
There have also been many studies of the conformational
effects of N-glycosylation on small peptides [8,9,11–13].
The general conclusions from these studies are that
N-glycosylation does not induce any permanent sec-
ondary structure in unstructured peptides but that it does
alter the conformational preferences of the peptide back-
bone in the vicinity of the glycosylation site, leading to a
higher probability of more compact conformations. These
effects seem to involve only the first few residues of the
glycan and are probably mediated by steric and hydropho-
bic or hydrophilic interactions between the core glycan
residues and the neighbouring amino acid sidechains.
(Similar results have been obtained in studies of O-linked
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The combination of conformational data obtained from NMR, molecular
modelling and X-ray crystallography enable individual glycosidic linkages
to be characterised. (a) to (c) show φ (H1—C1—O2′—C2′ torsion angle)
versus ψ (C1–O2′—C2′—H2′ torsion angle) plots for a Manα1—2Manα
glycosidic linkage. (a) Distance constraints obtained from NOE data
using the two-spin approximation for the D1—C linkage of Man9GlcNAc2
[7]. Four interproton distance constraints can be obtained from the
solution NMR data, which would be sufficient to define completely a
glycosidic linkage that adopted a single conformation. Each set of
contours on the φ/ψ plot (colour-coded) shows the region of
conformational space consistent with a single observed NOE. There is
no region that is consistent with all four observed NOEs. Thus, the
linkage must either be highly flexible or adopt more than one
conformation. A region at (–50°, +50°) fits three out of the four NOEs.
The NMR results are consistent with a φ angle of –50° and a range of ψ
angles between –60° to +60°, with more constraints consistent with the
higher values of ψ. (b) Results for the D1–C linkage of an unrestrained
molecular dynamics simulation of Man9GlcNAc2 [7]. Each dot
represents a snapshot of the structure at 1 ps intervals. The linkage
conformations clearly fall into two distinct groups with an average φ
angle of –40° and a ψ angle of –40° (green) or +70° (blue), the latter
being more populated. The linkage spends a long time (hundreds of
pico seconds) in each conformation before swapping rapidly to the
other. (c) All the crystallographic structures available for Manα1—2Manα
linkages [1]. The structures fall into two distinct groups (coloured blue
and green) with an average φ angle of –50° and a ψ angle of –55° or
+20°, the latter being more common. The dark blue dot is the crystal
structure of the Manα1—2Manα—OMe disaccharide. (d) Molecular
models of the two distinct conformations for the Manα1—2Manα
linkage, left (–50°, +50°), right (–50°, –50°). These are in dynamic
equilibrium, the equilibrium lying slightly more to the left. Each distinct
conformer is not static but shows limited oscillations for both φ and ψ.
glycopeptides [14] and particularly of heavily O-glycosy-
lated mucins [15]).
Glycans attached to proteins
There are relatively few examples of glycoproteins where
extensive structural data on both the peptide and glycan
components are available. The main examples are discussed
below and illustrate how local environment can lead to dif-
ferent orientations of an N-glycan with respect to its
protein. Possibly the most important point to emerge from
the examples below is the long-range stabilisation of the ter-
tiary or quaternary fold of a protein by addition of a glycan.
CD2
CD2 is a cell-surface glycoprotein involved in cell–cell
recognition. The extracellular part of the molecule con-
sists of two glycosylated immunoglobulin domains. The
crystal structure of soluble CD2 has been solved [16], but
only after enzymatically removing the glycans to leave a
single GlcNAc residue prior to crystallisation. Solution
structures of domain 1 have been determined by NMR for
the unglycosylated domain [17] and for both the peptide
[18] and glycan [19] components of the glycosylated
domain. There are no significant differences in the
polypeptide conformation of domain 1 among the three
structures. Thus, as expected, the presence of the glycan
does not alter the basic immunoglobulin fold.
Interestingly, the presence of the protein does not seem
to alter significantly the average glycan structure,
although it does reduce the flexibility of the core residues,
probably due to the interactions with the protein surface
[20]. Direct peptide–glycan contacts are seen between the
first two GlcNAc residues of the glycan and seven amino
acid sidechains (two asparagine, aspartate, two lysine,
phenylalanine and threonine) of the peptide [20]. The
glycosylated asparagine residue is on the surface of the
protein, and so these interactions result in the whole
glycan lying parallel to the peptide surface (Figure 3a). 
Ribonuclease B
Bovine pancreatic ribonuclease is a mixture of two forms
with identical peptide sequence, the aglycosyl ribonucle-
ase A and the monoglucosylated ribonuclease B. In con-
trast to CD2, ribonuclease B was crystallised with intact
glycans. A direct comparison of the X-ray structures of
ribonuclease A and B shows no statistically significant dif-
ferences in the peptide [21].
In the ribonuclease B crystal structure, electron density can
be seen for the glycan extending away from the peptide
surface into the solvent. This density is discontinuous and
cannot be interpreted in terms of a single glycan structure,
suggesting that the glycans are either disordered or mobile
within the crystal [21]. The NMR parameters for the glycan
component of ribonuclease B are virtually identical to those
of the free glycan. Thus, again the peptide does not seem to
be affecting the average glycan conformation in solution.
However, the situation is very different if the dynamic
properties of the peptide and glycan components are inves-
tigated. The presence of the glycan reduces solvent access
to many regions of the peptide backbone both close to and
remote from the glycosylation site (Figure 4), suggesting
that it reduces fluctuations of the backbone [22]. This is
confirmed by circular dichroism (CD) studies that indicate
that the glycan has a small stabilising effect on the peptide
fold [22]. 1H relaxation-rate measurements suggest that the
glycan component is not freely moving with respect to the
peptide component but that some of the glycan residues
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Figure 2
Molecular dynamics results on Man9GlcNAc2
[7]. (a) Overlay of individual snapshots taken at
100 ps intervals. The glycan arms are colour-
coded (dark blue, Man3GlcNAc2 core; light
blue, 3-arm; green and yellow, two 6-arms). The
overall topology of the molecule is well
preserved, given the high degree of flexibility for
each individual linkage (example in Figure 1).
(b) Single snapshot of Man9GlcNAc2 showing
the positions of water molecules (red spheres)
involved in interarm hydrogen bonding,
together with their occupancies based on the
molecular dynamics results.
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have similar mobilities to the amino acid sidechains,
whereas others have considerably more dynamic freedom
[23]. Importantly, the glycan has a significant effect on the
peptide dynamics, whereas the peptide seems to have a
smaller and more localised effect on the glycan dynamics.
Human chorionic gonadotrophin
The hormone human chorionic gonadotropin (hCG) is a
heterodimer with both the α and β chains glycosylated. A
crystal structure is available for hCG [24] but partial degly-
cosylation (using hydrofluoric acid) was required before
crystallisation. NMR studies on the free α subunit show
that deglycosylation does not notably affect the peptide
conformation [25]. However, deglycosylation does reduce
the thermal stability of the α subunit [26].
NMR studies on isotopically 13C,15N-enriched α chain in
the intact hCG dimer have shown that the glycans seem to
extend into the solvent, having similar conformational
properties to the free oligosaccharides [27]. No NOEs
were observed between the peptide and the glycans [27].
In contrast, NMR studies on the free α subunit have
shown extensive contacts between the first two GlcNAc
residues of the glycan at Asn78 and the peptide hydropho-
bic core [25,28], leading to a reduction in mobility of the
core glycan residues. These extensive interactions result
from the linkage site being situated in a pocket in the
protein surface, with the first two glycan residues making
contacts with the sides of the pocket. This orientates the
remainder of the glycan out into the solution (Figure 3b).
Immunoglobulin G Fc
The first glycoprotein to be crystallised was immunoglob-
ulin G Fc (IgG Fc). The structure at 3.5 Å resolution [29]
showed that the two glycans occupy the space between
the CH2 domains, with extensive contacts between the
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Figure 4
The presence of the glycan (light blue) on ribonuclease B reduces the
amide proton/deuterium exchange rates compared with ribonuclease A
for extensive regions of the peptide backbone (shown in red) both
local to and remote from the glycosylation site [34]. The glycoprotein
structure is based on the crystal structure of ribonuclease B [21] and
one of the structures of Man9GlcNAc2 determined by NMR and
molecular dynamics [7]. 
Structure
Figure 3
The position of the asparagine sidechain (dark
blue) and the interactions between the glycan
(light blue) and the local surface of the peptide
determine the presentation of the glycan. The
coloured bars show the surface of the protein
local to the glycosylation site. The glycans
interact with the red areas but not with the
green areas. (a) One of the NMR structures of
glycosylated domain 1 of CD2 [20]. The
glycosylated asparagine is on the peptide
surface. However, interactions of the glycan
core with the peptide orient the entire glycan
parallel to the surface. (b) Part of the hCG
crystal structure [24] with a modelled glycan at
Asn78. The glycosylated asparagine is in a
pocket on the protein surface. Although there
are extensive interactions of the glycan core
with the peptide, the entire glycan is oriented
away from the peptide surface. The glycan was
built using the database of average
crystallographic glycosidic linkages [1] and
added to the crystal structure by overlaying the
first GlcNAc residue. (c) The crystal structure
of the CH2 region of IgG Fc [33]. The
glycosylated asparagine is on a loop pointing
away from the peptide surface. However,
extensive interactions of the whole of the
glycan core and 6-arm with the peptide result
in the glycan lying along the surface.
(a) (b) (c)
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peptide and the glycans (Figure 3c). These interactions
lead to a distortion of the glycosidic linkage involving the
glycan 6-arm terminal galactose residue [1]. 13C [30] and
1H [31] NMR relaxation studies in solution have shown
the glycans to have the same dynamic properties as the
peptide, thus their immobilisation is not a crystal artefact.
Removal of the terminal 6-arm galactose residues results
in increased mobility of the entire glycan [31]. The
crystal structure of IgG Fc with missing 6-arm galactose
residues gives no resolvable density for the glycans [32],
also indicating increased glycan mobility. Thus, in con-
trast to the previous examples, the peptide significantly
affects the glycan conformation and the orientation of the
glycan with respect to the peptide surface is determined
by strong interactions involving the terminal galactose
(rather than just the chitobiose core). Comparison of the
agalacto X-ray structure with normal IgG Fc reveals no
changes to the peptide backbone within the domains, but
the lower hinge region is disordered in the agalacto struc-
ture [32]. Thus, the glycans seem to alter/stabilise the Fc
quaternary structure.
Glycoproteins at the cell surface
The majority of glycoproteins, such as CD2, are found at
the cell surface. The interactions between such proteins
involved in cell–cell recognition events are frequently
weak. Strong cell–cell interactions are obtained from many
such interactions occurring simultaneously on two comple-
mentary surfaces, providing a high level of specificity.
The complementarity of these surfaces will depend not
only on their composition but also on the presentation,
spatial organisation and diffusion rates of the many cell-
surface proteins involved. The glycans on these molecules
will affect their orientation and their packing on the cell
surface (Figure 5). This means that frequently important
biological effects of glycosylation may only be manifest in
the in vivo situation.
Conclusions
Even though only a limited number of glycoproteins have
so far been studied in detail, the following points seem to
be emerging. First, the presentation of an N-linked glycan
on a glycoprotein is determined, in most cases, by interac-
tions between the surface and the first couple of glycan
residues. Second, linkage of a glycan to a protein rarely
changes the average structure of the glycan. The glycan
residues are usually more mobile than the protein to
which they are attached but the mobility of the core
residues is reduced. Third, N-glycosylation of a folded
protein (in contrast to the glycosylation of peptides) does
not affect the average backbone fold. It does, however,
seem to have a significant stabilising effect on large
regions of the backbone structure remote from the glycan,
presumably by reducing the backbone flexibility. The
presentation of the glycans on glycoproteins can affect
their availability for recognition by lectins but may also
play a role in modulating protein organisation on cell sur-
faces.The most general structural effect of protein glyco-
sylation may turn out to be the alteration of the dynamics
of both the peptide and glycan parts of the structure.
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